Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer

The aims of this phase I/II study of docetaxel and S-1 were to determine the dose-limiting toxicity (DLT), maximum-tolerated dose (MTD), and recommended dose (RD) in the phase I part and to explore the tumour response, survival and safety in the phase II part. Patients with histologically- or cytolo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yamaguchi, K, Shimamura, T, Hyodo, I, Koizumi, W, Doi, T, Narahara, H, Komatsu, Y, Kato, T, Saitoh, S, Akiya, T, Munakata, M, Miyata, Y, Maeda, Y, Takiuchi, H, Nakano, S, Esaki, T, Kinjo, F, Sakata, Y
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2006
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361339/
https://ncbi.nlm.nih.gov/pubmed/16773074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603196
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars